Proteovista Nets $643K NIH Grant to Develop Array Platform for Cardiac Biomarker Discovery | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded Proteovista a two-year, $643,000 grant to develop a new microarray platform for identifying biomarkers associated with various cardiovascular diseases.

Based in Madison, Wis., Proteovista was initially called Illumavista Bioscience until it changed its name in August 2013 following a legal dispute over the moniker with San Diego-based Illumina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.